Gossamer Bio (GOSS) Amortization of Deferred Charges (2022 - 2025)
Gossamer Bio's Amortization of Deferred Charges history spans 4 years, with the latest figure at $251000.0 for Q4 2025.
- For Q4 2025, Amortization of Deferred Charges rose 5.46% year-over-year to $251000.0; the TTM value through Dec 2025 reached $523000.0, down 6.77%, while the annual FY2025 figure was $985000.0, 9.3% down from the prior year.
- Amortization of Deferred Charges reached $251000.0 in Q4 2025 per GOSS's latest filing, up from $16000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $352000.0 in Q1 2023 to a low of $13000.0 in Q2 2022.
- Average Amortization of Deferred Charges over 4 years is $147500.0, with a median of $127000.0 recorded in 2024.
- Peak YoY movement for Amortization of Deferred Charges: increased 20.55% in 2023, then dropped 22.73% in 2024.
- A 4-year view of Amortization of Deferred Charges shows it stood at $270000.0 in 2022, then rose by 14.07% to $308000.0 in 2023, then decreased by 22.73% to $238000.0 in 2024, then grew by 5.46% to $251000.0 in 2025.
- Per Business Quant, the three most recent readings for GOSS's Amortization of Deferred Charges are $251000.0 (Q4 2025), $16000.0 (Q3 2025), and $15000.0 (Q2 2025).